Carla Tardif: Children with cancer from low-income households are three times more likely to die and two times more likely to relapse than their counterparts

MD Anderson Research Highlights

Phase 3 EVER-002 trial is out

Yakup Ergün: Curative ICIs therapy in patients with dMMR locally advanced rectal cancer

FDA approved Neoadjuvant/Adjuvant Nivolumab for resectable NSCLC

The results of the TOPGEAR trial on gastric and GEJ adenocarcinoma – EORTC

What is the difference between chemotherapy and immunotherapy – CRI

Justin Stebbing: How to deal with chemotherapy side effects

Shankar Siva: QoL outcomes in the adaptive radiotherapy SPRINT PET trial

Tom Powles: 1st perioperative immune therapy study to show an OS in bladder cancer